Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pavel Lyatoshinsky

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
European Urology Focus|April 28, 2022
Prostatic Artery Embolisation: Do We Still Need It and for Whom?Dominik Abt, Pavel Lyatoshinsky, Hans-Peter Schmid, et al.
Urology Case Reports|February 23, 2023
Spindle cell/pleomorphic lipoma of the seminal vesicle: First description of a rare benign mesenchymal tumorPavel Lyatoshinsky, Manolis Pratsinis, Eva Markert, et al.
Cardiovascular and Interventional Radiology|January 19, 2022
Minimally Invasive Therapies for Benign Prostatic Obstruction: A Review of Currently Available Techniques Including Prostatic Artery Embolization, Water Vapor Thermal Therapy, Prostatic Urethral Lift, Temporary Implantable Nitinol Device and AquablationTiago Bilhim, Patrick Betschart, Pavel Lyatoshinsky, et al.
BMC Urology|April 24, 2025
Surgical treatment of lower urinary tract symptoms secondary to benign prostatic obstruction: an analysis and meta-synthesis of available guidelinesLaurenz S Matter, Orlando Burkhardt, Pavel Lyatoshinsky, et al.
Swiss Medical Weekly|April 5, 2022
In-hospital cost analysis of aquablation compared with transurethral resection of the prostate in the treatment of benign prostatic enlargementGautier Müllhaupt, Pavel Lyatoshinsky, Anne Neuenschwander, et al.
Current Urology|November 27, 2019
Readability Assessment of Commonly Used German Urological QuestionnairesPavel Lyatoshinsky, Manolis Pratsinis, Dominik Abt, et al.
Journal of Clinical Medicine|June 2, 2021
Characteristics of the Urinary Proteome in Women with Overactive Bladder Syndrome: A Case-Control StudyMarianne Koch, Pavel Lyatoshinsky, Goran Mitulovic, et al.
BMC Urology|May 11, 2023
Guidance of adjuvant instillation in intermediate-risk non-muscle invasive bladder cancer by drug screens in patient derived organoids: a single center, open-label, phase II trialRoland Seiler, Martin Egger, Marta De Menna, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
European Urology Focus|April 28, 2022
Prostatic Artery Embolisation: Do We Still Need It and for Whom?Dominik Abt, Pavel Lyatoshinsky, Hans-Peter Schmid, et al.
Urology Case Reports|February 23, 2023
Spindle cell/pleomorphic lipoma of the seminal vesicle: First description of a rare benign mesenchymal tumorPavel Lyatoshinsky, Manolis Pratsinis, Eva Markert, et al.
Cardiovascular and Interventional Radiology|January 19, 2022
Minimally Invasive Therapies for Benign Prostatic Obstruction: A Review of Currently Available Techniques Including Prostatic Artery Embolization, Water Vapor Thermal Therapy, Prostatic Urethral Lift, Temporary Implantable Nitinol Device and AquablationTiago Bilhim, Patrick Betschart, Pavel Lyatoshinsky, et al.
BMC Urology|April 24, 2025
Surgical treatment of lower urinary tract symptoms secondary to benign prostatic obstruction: an analysis and meta-synthesis of available guidelinesLaurenz S Matter, Orlando Burkhardt, Pavel Lyatoshinsky, et al.
Swiss Medical Weekly|April 5, 2022
In-hospital cost analysis of aquablation compared with transurethral resection of the prostate in the treatment of benign prostatic enlargementGautier Müllhaupt, Pavel Lyatoshinsky, Anne Neuenschwander, et al.
Current Urology|November 27, 2019
Readability Assessment of Commonly Used German Urological QuestionnairesPavel Lyatoshinsky, Manolis Pratsinis, Dominik Abt, et al.
Journal of Clinical Medicine|June 2, 2021
Characteristics of the Urinary Proteome in Women with Overactive Bladder Syndrome: A Case-Control StudyMarianne Koch, Pavel Lyatoshinsky, Goran Mitulovic, et al.
BMC Urology|May 11, 2023
Guidance of adjuvant instillation in intermediate-risk non-muscle invasive bladder cancer by drug screens in patient derived organoids: a single center, open-label, phase II trialRoland Seiler, Martin Egger, Marta De Menna, et al.
Pageof 1